SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Elon Musks warning that tighter debt markets could trigger failures and consolidation among AI neoclouds has fueled concern about Nebius and the broader sector. Traders are divided: bears see financing risks, while bulls argue Nebius is better positioned because it secured a large Citi credit facility and says it has funding to complete planned expansion.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Elon Musks warning that many neocloud providers could fail or consolidate has intensified scrutiny of CoreWeaves debt-heavy expansion and access to financing. Traders are split between fears of mounting credit pressure and bankruptcy risk and the view that strong AI demand and Nvidia ties could help CoreWeave weather a sector shakeout.

iShares Inc. - iShares MSCI Brazil ETF

iShares MSCI Brazil ETF

Brazils presidential runoff result, with Lula defeating the market-favored Bolsonaro, is driving discussion of a sharp EWZ selloff and heightened political and economic uncertainty. Traders debate whether the move is an overreaction and buying opportunity, while others point to downside hedging and further risk.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

A broad biotech-sector pullback, which traders attribute to rising-rate concerns, risk-off sentiment and rotation away from small-cap growth, is driving discussion around XBI. Some see support near its 200-day average and are buying the dip, while others warn the decline may continue; upcoming biotech data and M&A activity are viewed as potential supports but not confirmed catalysts.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

AXSMs steep selloff has focused attention on whether Auvelitys launch for Alzheimers-related agitation is gaining traction, with investors looking to the Q3 results for clearer prescription and sales evidence. Bulls argue that samples and long-term-care channels may be obscuring uptake, while skeptics point to lackluster visible prescription growth, high spending and managements silence as sources of uncertainty.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivians upcoming quarterly results and forward guidance are the main focus, with traders debating whether delivery growth and the R2 ramp can translate into better margins and lower cash burn. The stocks slide to fresh lows has split sentiment between hopes for a rebound on strong results and concerns about continued losses, execution, and dilution.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

XLE is drawing attention for its energy-sector rally and record highs, which traders link to elevated oil prices and supply-disruption fears tied to conflict around the Strait of Hormuz and attacks on energy infrastructure. The community is broadly bullish on the sectors strength, though some see the move as overextended or vulnerable if tensions ease or a technical breakout fails.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

Sharp swings in South Korean equitiesespecially chip-heavy Samsung and SK Hynixare driving discussion, with traders linking the pressure to concerns about AI-related stocks and debating whether KORUs steep drop is an oversold buying opportunity or a warning of further losses. The ETFs 3x daily leverage magnifies the volatility, while Goldman Sachs lower KOSPI outlook adds to the bearish case.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Anticipation around Sanofis COVID/flu combination vaccine Phase 3 start and Novavaxs upcoming earnings is driving discussion, with traders watching for a potential milestone payment and evidence of stronger commercial revenue. Bulls see the partnership as a path toward breakeven, while skeptics question whether the trial has started and criticize managements limited communication; proposed Pfizer use of Matrix-M remains speculation.

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.

Natera Inc

Nateras strong run and repeated 52-week highs are driving attention, with traders citing momentum and optimism around its oncology diagnostics and MRD business, including a breakthrough-device designation for its investigational early-cancer assay. Some see room for the rally to continue, while others flag overbought conditions, valuation, and profit-taking risk; the designation is not an FDA approval.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Jeffrey Ostrom

$DvlT  and $ecgI  were dipping  But new uptrend told by Millionairetrader555 is 
 $MDeX  ☝️MillionaireTrader555   11:34 AM 
First $TIPS then $NBND next up $MDEX